The Childhood Cancer Blog

The Childhood Cancer Blog

Welcome to The Childhood Cancer Blog
from Alex's Lemonade Stand Foundation!

  • “It's simple, you see for this whole thing isn't about me. As long as kids are sick, I'll do what I can to help raise money through my lemonade stand.” - Alexandra “Alex” Scott (January 18, 1996 – August 1, 2004)
  • “Alex showed us that a life lived with gratitude allows you to overcome challenges – that you can truly make lemonade from lemons!” - Liz Scott, Alex’s Mom
  • “I could remember you as a lot of things: the lemonade girl, a childhood cancer victim, my close friend, my little sister. But none of them do you justice; you would not be you if they were not all true. More than anything else, I remember you for what you taught me. You, as a terminally ill child, were still appreciative of the blessings that you had. To me, that describes you better than any label, encapsulates your image better than any picture--it reminds me that even though you were never old in age, in some ways, you were old in wisdom. For the lessons that you taught me, I will always remember you and I will always be grateful.” - Patrick Scott, Alex’s Brother

I can’t believe it’s been 14 years since I had the pleasure of hearing my daughter Alex’s voice, seeing her smile, and just sitting alongside her. A lot has happened since then!  

When I first lost Alex, I could not imagine my life without her. Of course my three sons kept me going and gave me a reason to smile and keep moving forward. But looking back on it, I realize that even in her absence, Alex also gave me a reason to smile and keep moving forward. She left work to be done to reach her dream of a cure for all children with cancer. She also left a lifetime of lessons about... Read More

  • DIPG is a rare but lethal tumor that occurs in the brainstem. It mixes cancer cells with normal cells. About 300-400 children are diagnosed each year and live an average of 10 months after diagnosis.
  • Michelle Monje, pictured here at her lab at Stanford University. In addition to DIPG research, Dr. Monje also studies spinal cord tumors, which can share genetic characteristics similar to high-grade gliomas like DIPG. Dr. Monje is also the co-chair for the High-Grade Glioma section at ALSF's Crazy 8 meeting this September in Philadelphia.
  • Kayne Finley was a kind and compassionate high school senior. In October 2016, Kayne experienced unusual health issues which led to a diagnosis of DIPG. One year and one day later, Kayne passed away. Kayne is pictured above with his mother, brother and father. 
  • For doctors to find cures for lethal brain tumors, they need tissue samples. However, samples from a biopsy are often only enough for a clinician to use to determine the diagnosis. There is typically little left over for research purposes. Families and patients can make profound and meaningful gifts by donating post-mortem tissue to research labs to help doctors replicate, model and study tumors in ways not possible before. In the months before his death, Kayne, pictured above, signed a directive ensuring his tumor could be donated for DIPG research.

by Trish Adkins

When a child receives the diagnosis of diffuse intrinsic pontine glioma (DIPG), the diagnosis comes with an end date. 

Thus far, DIPG is always lethal. 

But, ALSF-funded grantee Dr. Michelle Monje of Stanford University, does not believe it has to be. Dr. Monje, who specializes in studying high-grade gliomas, is close to a powerful breakthrough that could change the prognosis for children with DIPG.

... Read More

Above, this map shows the RNA clustering of childhood cancer PDX models. RNA works as a messenger inside of cells, carrying instructions from DNA for controlling cellular activities, like cell division.

by Trish Adkins

In 2000, the first draft of the map of human genome—a mosaic representation of characteristics of what makes our biology uniquely human—was released. The map paved the way for more genomics research in several fields ranging from human biology to agriculture and gave scientists models of genetically normal cells which they could compare to abnormal cells, like those cells that make childhood cancer so deadly.

Now, in 2018, an ALSF funded-research project has resulted in the release of over 270 genetic sequences of 25 different types of childhood cancer used... Read More

Pages